This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
CNOOC Engages with Canadian Stakeholders - Teaching Note
Klaus MeyerTeaching Note IVEY-8B17M005-EStrategyTeaching note for product 9B17M005.Starting at €0.00
-
Bossard AG: Enabling Industry 4.0 Logistics, Worldwide - Teaching Note
Klaus Meyer; Alexandra HanTeaching Note IVEY-8B17M149-EStrategyTeaching note for product 9B17M149.Starting at €0.00
-
BMW Mini: Big Decisions Under the Brexit Cloud
Klaus Meyer; Ken MarkCase IVEY-9B19M013-EStrategyIn April 2017, BMW AG (BMW) faced a big decision regarding which plant should receive the mandate to produce the first electric version of BMW’s iconic Mini car. The leadership team of BMW’s UK operations was determined to keep the Mini at its historical home base in the United Kingdom. However, given the uncertainty arising from the United Kingdom’s decision to leave the European Union—a move commonly known as “Brexit” —how would the team be abl...Starting at €8.20
-
Bossard AG: Enabling Industry 4.0 Logistics, Worldwide (Spanish Version)
Klaus Meyer; Alexandra HanCase IVEY-9B17MS149StrategyIn 2016, Bossard AG was a leading wholesaler and supply chain service provider for fasteners. Its business model aimed to improve the efficiency of clients’ manufacturing operations by applying Industry 4.0 technologies to integrate the delivery of the highest quality screws, nuts, and bolts with logistics solutions for supply chains, and technical solutions for product designs using fasteners. Bossard’s key selling point was its ability to enhan...Starting at €8.20
-
Ethics of Offshoring: Novo Nordisk and Clinical Trials in Emerging Economies
Klaus MeyerCase IVEY-9B09M001-EStrategyThe case outlines the conflicting ethical demands on a Danish pharmaceuticals company, Novo Nordisk, that is operating globally and is aspiring to high standards of corporate social responsibility. A recent report alleges that multinational pharmaceutical companies routinely conduct trials in developing countries under alleged unethical conditions. The company's director reflects on how to respond to a request from a journalist for an interview. ...Starting at €8.20